Our NAREIT FFO for the third quarter was $159 million or $0.65 per share as compared to $181 million or $0.73 per share for the third quarter of 2021.
Our third quarter adjusted FFO is $0.76 per share and funds available for distribution are $0.71 per share.
Our current quarter FAD per share of $0.71 compares favorably to our pre-COVID first quarter 2020 FAD per share of $0.74, particularly when you consider the FAD per share upside from the nearly complete Agemo restructuring.
We believe that we will continue to grapple with ongoing COVID-related operator issues for the next 12 to 16 months.
We have maintained our quarterly dividend of $0.67 per share.
In addition, the redeployment of the Agemo asset sale proceeds are expected to add another $0.03 per share to quarterly FAD.
Revenue for the third quarter was approximately $239 million before adjusting for certain nonrecurring items compared to $282 million for the third quarter of 2021.
It is anticipated that 1 additional facility in Florida would be sold in the coming weeks.
As of today, we have $435 million in cash, which includes the proceeds received from the Agemo asset sales completed in the fourth quarter.
Six, the extension of our $1.5 billion revolving credit agreement through 2025.
Our next debt maturity is $350 million of 4 3/8% notes due August of 2023.
Year-to-date FAD is $2.07 per share, while our year-to-date dividend paid is $2.01 per share.
Early in 2023, we expect Agemo to begin paying rent and interest on the balance of the 29 facilities that they retained in the restructuring and anticipate the rent and interest on the Agemo retained portfolio will add nearly $0.03 per share to quarterly FAD.
Trailing 12-month operator EBITDARM and EBITDAR coverage for our core portfolio as of June 30, 2022, decreased to 1.39 and 1.06x, respectively, versus 1.44x and 1.1x, respectively, for the trailing 12-month period ended March 31, 2022.
However, there started to be slight positive momentum with an average of 4,600 nursing home jobs per month added from March 2022 through July 2022.
At September 30, 98% of our $5.3 billion in debt was at fixed rates and our net funded debt-to-annualized adjusted EBITDA was 5.3x, the same as both our first and second quarter.